Enhertu, which can give patients an extra seven months to live on average, has been prescribed in Scotland for more than two ...
Thousands with HER2-low advanced breast cancer will have access to Enhertu after ministers strike deal on price ...
By Nancy Lapid Sept 15 (Reuters) - Hello Health Rounds readers! Today we highlight a potentially game-changing experimental ...
Moderna and Merck's Phase 3 melanoma vaccine trial showed positive results, but full data and FDA approval are still pending ...
If a new drug's the survival benefit is confirmed in the next leg of a late-stage study, the drug could provide a ...
Cancer science made major progress in the past year but faces an “inflection point” amid funding threats, according to a ...
Women with incurable breast cancer will be given a life-extending drug on the NHS after health-spending watchdogs reversed a ...
Blood test shows promise in detecting pancreatic cancer early—a 'Holy Grail' for the field Pancreatic cancer is typically ...
Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and ...
A Minnesota woman diagnosed with stage 3B ovarian cancer after her best friend died from the same disease urges women to ...